25021-262Level 3
BORTEZOMIB (BORTEZOMIB)
**Product type:** Human Prescription Drug
**Active ingredient:** BORTEZOMIB
**Strength:** 3.5 mg/1
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Intravenous; Subcutaneous
**Labeler:** Sagent Pharmaceuticals
**Marketing category:** ANDA (ANDA210824)
**Pharmacologic class:** Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/25021-262Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.